A comprehensive ingredient-level analysis of the nine-compound liquid dropper supplement, examining scientific research, ...

Neighborhood-level social determinants of health were associated with varying cancer risks and greater mortality among kidney ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

By Oluseye OjoIn Nigeria, prostate cancer is a silent killer of men, claiming approximately 31 lives daily.In 2022, records showed that the country recorded 18,019 new cases, resulting in 11,443 ...

The APP ordered a bilateral diagnostic mammogram and left breast ultrasound that revealed extremely dense breast tissue, a ...

Diagnostic evaluation should follow principle of 'as low as reasonably achievable'; systemic therapy should be deferred until second trimester ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

Here are the top 5 stories from 2025 about the advancements in prostate, kidney, and bladder cancers.

By Dr Wendy Winnall - PCFA Research TeamA recent prostate cancer study from Canada has received a lot of publicity. This study measured the risk of ...

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of ...

For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...